SILDENAFIL ORAL SUSPENSION (Revatio®)
Clinical Indication
Pulmonary artery hypertension
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.